ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Biopsy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35N5693
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Cancer Biopsy Market Insights Forecast to 2028
BUY CHAPTERS

Global Cancer Biopsy Market Research Report 2025

Code: QYRE-Auto-35N5693
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
QIAGEN N V
Illumina Inc
Angle plc
Myriad Genetics
Hologic Inc
Biocept
Thermo Fisher Scientific Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics, Inc.

Cancer Biopsy Market

The global market for Cancer Biopsy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
North American market for Cancer Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Biopsy in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, Lucence Diagnostics Pte. Ltd., GRAIL, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy.
The Cancer Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Biopsy Market Report

Report Metric Details
Report Name Cancer Biopsy Market
Segment by Type
  • Tissue Biopsies
  • Liquid Biopsies
  • Others
Segment by Application
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health, Exact Sciences Corporation, Freenome Holdings, Inc., Oncimmune, Chronix Biomedical, Inc., Personal Genome Diagnostics Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Biopsy Market report?

Ans: The main players in the Cancer Biopsy Market are Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health, Exact Sciences Corporation, Freenome Holdings, Inc., Oncimmune, Chronix Biomedical, Inc., Personal Genome Diagnostics Inc.

What are the Application segmentation covered in the Cancer Biopsy Market report?

Ans: The Applications covered in the Cancer Biopsy Market report are Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Others

What are the Type segmentation covered in the Cancer Biopsy Market report?

Ans: The Types covered in the Cancer Biopsy Market report are Tissue Biopsies, Liquid Biopsies, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Biopsies
1.2.3 Liquid Biopsies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Biopsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biopsy Market Perspective (2020-2031)
2.2 Global Cancer Biopsy Growth Trends by Region
2.2.1 Global Cancer Biopsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Biopsy Historic Market Size by Region (2020-2025)
2.2.3 Cancer Biopsy Forecasted Market Size by Region (2026-2031)
2.3 Cancer Biopsy Market Dynamics
2.3.1 Cancer Biopsy Industry Trends
2.3.2 Cancer Biopsy Market Drivers
2.3.3 Cancer Biopsy Market Challenges
2.3.4 Cancer Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biopsy Players by Revenue
3.1.1 Global Top Cancer Biopsy Players by Revenue (2020-2025)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Biopsy Revenue
3.4 Global Cancer Biopsy Market Concentration Ratio
3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2024
3.5 Global Key Players of Cancer Biopsy Head office and Area Served
3.6 Global Key Players of Cancer Biopsy, Product and Application
3.7 Global Key Players of Cancer Biopsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biopsy Breakdown Data by Type
4.1 Global Cancer Biopsy Historic Market Size by Type (2020-2025)
4.2 Global Cancer Biopsy Forecasted Market Size by Type (2026-2031)
5 Cancer Biopsy Breakdown Data by Application
5.1 Global Cancer Biopsy Historic Market Size by Application (2020-2025)
5.2 Global Cancer Biopsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Biopsy Market Size (2020-2031)
6.2 North America Cancer Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Biopsy Market Size by Country (2020-2025)
6.4 North America Cancer Biopsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Biopsy Market Size (2020-2031)
7.2 Europe Cancer Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Biopsy Market Size by Country (2020-2025)
7.4 Europe Cancer Biopsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biopsy Market Size (2020-2031)
8.2 Asia-Pacific Cancer Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Biopsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Biopsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Biopsy Market Size (2020-2031)
9.2 Latin America Cancer Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Biopsy Market Size by Country (2020-2025)
9.4 Latin America Cancer Biopsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biopsy Market Size (2020-2031)
10.2 Middle East & Africa Cancer Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Biopsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Biopsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Biopsy Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2020-2025)
11.1.5 Qiagen N.V. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cancer Biopsy Introduction
11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.2.5 Illumina, Inc. Recent Development
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Details
11.3.2 ANGLE Plc Business Overview
11.3.3 ANGLE Plc Cancer Biopsy Introduction
11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2020-2025)
11.3.5 ANGLE Plc Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Cancer Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2020-2025)
11.4.5 Myriad Genetics Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Cancer Biopsy Introduction
11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.5.5 Hologic, Inc. Recent Development
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Details
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Cancer Biopsy Introduction
11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.6.5 Biocept, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Cancer Biopsy Introduction
11.8.4 Danaher Revenue in Cancer Biopsy Business (2020-2025)
11.8.5 Danaher Recent Development
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2020-2025)
11.9.5 Lucence Diagnostics Pte. Ltd. Recent Development
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Details
11.10.2 GRAIL, Inc. Business Overview
11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.10.5 GRAIL, Inc. Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Cancer Biopsy Introduction
11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2020-2025)
11.11.5 Guardant Health Recent Development
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Details
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2020-2025)
11.12.5 Exact Sciences Corporation Recent Development
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Details
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.13.5 Freenome Holdings, Inc. Recent Development
11.14 Oncimmune
11.14.1 Oncimmune Company Details
11.14.2 Oncimmune Business Overview
11.14.3 Oncimmune Cancer Biopsy Introduction
11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2020-2025)
11.14.5 Oncimmune Recent Development
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Details
11.15.2 Chronix Biomedical, Inc. Business Overview
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.15.5 Chronix Biomedical, Inc. Recent Development
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Details
11.16.2 Personal Genome Diagnostics Inc. Business Overview
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2020-2025)
11.16.5 Personal Genome Diagnostics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
QIAGEN N V
Illumina Inc
Angle plc
Myriad Genetics
Hologic Inc
Biocept
Thermo Fisher Scientific Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics, Inc.
List of Tables
 Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tissue Biopsies
 Table 3. Key Players of Liquid Biopsies
 Table 4. Key Players of Others
 Table 5. Global Cancer Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cancer Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancer Biopsy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cancer Biopsy Market Share by Region (2020-2025)
 Table 9. Global Cancer Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cancer Biopsy Market Share by Region (2026-2031)
 Table 11. Cancer Biopsy Market Trends
 Table 12. Cancer Biopsy Market Drivers
 Table 13. Cancer Biopsy Market Challenges
 Table 14. Cancer Biopsy Market Restraints
 Table 15. Global Cancer Biopsy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cancer Biopsy Market Share by Players (2020-2025)
 Table 17. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2024)
 Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cancer Biopsy, Headquarters and Area Served
 Table 21. Global Key Players of Cancer Biopsy, Product and Application
 Table 22. Global Key Players of Cancer Biopsy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cancer Biopsy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cancer Biopsy Revenue Market Share by Type (2020-2025)
 Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cancer Biopsy Revenue Market Share by Type (2026-2031)
 Table 28. Global Cancer Biopsy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cancer Biopsy Revenue Market Share by Application (2020-2025)
 Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cancer Biopsy Revenue Market Share by Application (2026-2031)
 Table 32. North America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cancer Biopsy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cancer Biopsy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cancer Biopsy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cancer Biopsy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cancer Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cancer Biopsy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cancer Biopsy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cancer Biopsy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cancer Biopsy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cancer Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cancer Biopsy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cancer Biopsy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Qiagen N.V. Company Details
 Table 48. Qiagen N.V. Business Overview
 Table 49. Qiagen N.V. Cancer Biopsy Product
 Table 50. Qiagen N.V. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 51. Qiagen N.V. Recent Development
 Table 52. Illumina, Inc. Company Details
 Table 53. Illumina, Inc. Business Overview
 Table 54. Illumina, Inc. Cancer Biopsy Product
 Table 55. Illumina, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 56. Illumina, Inc. Recent Development
 Table 57. ANGLE Plc Company Details
 Table 58. ANGLE Plc Business Overview
 Table 59. ANGLE Plc Cancer Biopsy Product
 Table 60. ANGLE Plc Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 61. ANGLE Plc Recent Development
 Table 62. Myriad Genetics Company Details
 Table 63. Myriad Genetics Business Overview
 Table 64. Myriad Genetics Cancer Biopsy Product
 Table 65. Myriad Genetics Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 66. Myriad Genetics Recent Development
 Table 67. Hologic, Inc. Company Details
 Table 68. Hologic, Inc. Business Overview
 Table 69. Hologic, Inc. Cancer Biopsy Product
 Table 70. Hologic, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 71. Hologic, Inc. Recent Development
 Table 72. Biocept, Inc. Company Details
 Table 73. Biocept, Inc. Business Overview
 Table 74. Biocept, Inc. Cancer Biopsy Product
 Table 75. Biocept, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 76. Biocept, Inc. Recent Development
 Table 77. Thermo Fisher Scientific, Inc. Company Details
 Table 78. Thermo Fisher Scientific, Inc. Business Overview
 Table 79. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
 Table 80. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 81. Thermo Fisher Scientific, Inc. Recent Development
 Table 82. Danaher Company Details
 Table 83. Danaher Business Overview
 Table 84. Danaher Cancer Biopsy Product
 Table 85. Danaher Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 86. Danaher Recent Development
 Table 87. Lucence Diagnostics Pte. Ltd. Company Details
 Table 88. Lucence Diagnostics Pte. Ltd. Business Overview
 Table 89. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
 Table 90. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 91. Lucence Diagnostics Pte. Ltd. Recent Development
 Table 92. GRAIL, Inc. Company Details
 Table 93. GRAIL, Inc. Business Overview
 Table 94. GRAIL, Inc. Cancer Biopsy Product
 Table 95. GRAIL, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 96. GRAIL, Inc. Recent Development
 Table 97. Guardant Health Company Details
 Table 98. Guardant Health Business Overview
 Table 99. Guardant Health Cancer Biopsy Product
 Table 100. Guardant Health Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 101. Guardant Health Recent Development
 Table 102. Exact Sciences Corporation Company Details
 Table 103. Exact Sciences Corporation Business Overview
 Table 104. Exact Sciences Corporation Cancer Biopsy Product
 Table 105. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 106. Exact Sciences Corporation Recent Development
 Table 107. Freenome Holdings, Inc. Company Details
 Table 108. Freenome Holdings, Inc. Business Overview
 Table 109. Freenome Holdings, Inc. Cancer Biopsy Product
 Table 110. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 111. Freenome Holdings, Inc. Recent Development
 Table 112. Oncimmune Company Details
 Table 113. Oncimmune Business Overview
 Table 114. Oncimmune Cancer Biopsy Product
 Table 115. Oncimmune Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 116. Oncimmune Recent Development
 Table 117. Chronix Biomedical, Inc. Company Details
 Table 118. Chronix Biomedical, Inc. Business Overview
 Table 119. Chronix Biomedical, Inc. Cancer Biopsy Product
 Table 120. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 121. Chronix Biomedical, Inc. Recent Development
 Table 122. Personal Genome Diagnostics Inc. Company Details
 Table 123. Personal Genome Diagnostics Inc. Business Overview
 Table 124. Personal Genome Diagnostics Inc. Cancer Biopsy Product
 Table 125. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2020-2025) & (US$ Million)
 Table 126. Personal Genome Diagnostics Inc. Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Cancer Biopsy Picture
 Figure 2. Global Cancer Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Biopsy Market Share by Type: 2024 VS 2031
 Figure 4. Tissue Biopsies Features
 Figure 5. Liquid Biopsies Features
 Figure 6. Others Features
 Figure 7. Global Cancer Biopsy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cancer Biopsy Market Share by Application: 2024 VS 2031
 Figure 9. Breast Cancer Case Studies
 Figure 10. Colorectal Cancer Case Studies
 Figure 11. Cervical Cancers Case Studies
 Figure 12. Lung Cancers Case Studies
 Figure 13. Prostate Cancers Case Studies
 Figure 14. Skin Cancers Case Studies
 Figure 15. Blood Cancers Case Studies
 Figure 16. Kidney Cancers Case Studies
 Figure 17. Others Case Studies
 Figure 18. Cancer Biopsy Report Years Considered
 Figure 19. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Cancer Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Cancer Biopsy Market Share by Region: 2024 VS 2031
 Figure 22. Global Cancer Biopsy Market Share by Players in 2024
 Figure 23. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2024
 Figure 25. North America Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Cancer Biopsy Market Share by Country (2020-2031)
 Figure 27. United States Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Cancer Biopsy Market Share by Country (2020-2031)
 Figure 31. Germany Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Cancer Biopsy Market Share by Region (2020-2031)
 Figure 39. China Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Cancer Biopsy Market Share by Country (2020-2031)
 Figure 47. Mexico Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Cancer Biopsy Market Share by Country (2020-2031)
 Figure 51. Turkey Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Cancer Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 55. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 56. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 57. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 58. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 59. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 61. Danaher Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 62. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 63. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 64. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 65. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 66. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 67. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 68. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 69. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Lung Biopsy Systems Market Research Report 2024
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Global Breast Biopsy Devices Market Insights Forecast to 2025
Skin Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tissue Testing Market Research Report 2024
Cancer Biopsy Instruments and Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Breast Biopsy Solution Market Research Report 2024
Breast Biopsy System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Core Needle Biopsy for Soft Tissue Market Research Report 2024
Global Cervical Biopsy Equipment Market Research Report 2024
Global Molecular Diagnostics Cancer Market Insights Forecast to 2030
Breast Cancer Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Soft Tissue Core Biopsy Needle Market Research Report 2024
Global Biopsy Equipment Market Research Report 2024
Global Aspiration Biopsy Needle Market Research Report 2024
Global Soft Tissue Core Biopsy Market Research Report 2024
Global Breast Cancer Testing Market Insights Forecast to 2030
Smart Biopsy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Biopsy Devices Market Research Report 2020
Soft Tissue Puncture Biopsy Needle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions